We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+26.99%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$12.5B
AUM Growth
+$844M
Cap. Flow
-$1.62B
Cap. Flow %
-12.95%
Top 10 Hldgs %
33.14%
Holding
137
New
32
Increased
25
Reduced
37
Closed
18

Top Buys

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$331M
2
AON icon
Aon
AON
+$321M
3
WUBA
58.com Inc
WUBA
+$256M
4
BMY icon
Bristol-Myers Squibb
BMY
+$217M
5
TIF
Tiffany & Co.
TIF
+$191M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$1.65B
2
CI icon
Cigna
CI
+$142M
3
FIS icon
Fidelity National Information Services
FIS
+$135M
4
GD icon
General Dynamics
GD
+$132M
5
WAB icon
Wabtec
WAB
+$113M

Sector Composition

Rank Sector Weight
1 Healthcare 43.19%
2 Communication Services 20.54%
3 Technology 10.42%
4 Financials 7.52%
5 Consumer Discretionary 4.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IQV icon
1
IQVIA
IQV
$42.8B
$539M 4.31%
3,796,030
+56,334
+2% +$7.63M
FIS icon
2
Fidelity National Information Services
FIS
$21.3B
$481M 3.85%
3,590,128
-1,031,080
-22% -$135M
PPLI
3
People Inc
PPLI
$2.86B
$456M 3.65%
7,889,525
-1,706,599
-18% -$75.8M
CNC icon
4
Centene
CNC
$32.1B
$445M 3.56%
7,000,000
-250,000
-3% -$16.3M
ABBV icon
5
AbbVie
ABBV
$468B
$407M 3.26%
4,150,000
+150,000
+4% +$13.2M
TMO icon
6
Thermo Fisher Scientific
TMO
$233B
$388M 3.1%
1,069,505
-173,710
-14% -$58.2M
CHTR icon
7
Charter Communications
CHTR
$17.9B
$385M 3.08%
755,015
+31,687
+4% +$16.1M
TMUS icon
8
T-Mobile US
TMUS
$196B
$360M 2.88%
+3,457,631
New +$331M
V icon
9
Visa
V
$693B
$348M 2.78%
1,799,373
+36,105
+2% +$6.6M
AON icon
10
Aon
AON
$75.3B
$331M 2.65%
+1,720,498
New +$321M
ELV icon
11
Elevance Health
ELV
$86.9B
$329M 2.63%
1,250,000
– –
GOOG icon
12
Alphabet (Google) Class C
GOOG
$4.18T
$312M 2.5%
4,421,000
-1,482,460
-25% -$100M
MSFT icon
13
Microsoft
MSFT
$3.59T
$311M 2.49%
1,528,199
-295,521
-16% -$53.6M
META icon
14
Meta Platforms (Facebook)
META
$1.4T
$308M 2.47%
1,358,494
+270,970
+25% +$56.6M
INFO
15
DELISTED
IHS Markit Ltd. Common Shares
INFO
$295M 2.36%
3,910,024
-1,015,514
-21% -$69.1M
CRM icon
16
Salesforce
CRM
$171B
$286M 2.29%
1,525,648
-88,840
-6% -$15M
WUBA
17
DELISTED
58.com Inc
WUBA
$268M 2.14%
+4,965,212
New +$256M
SHW icon
18
Sherwin-Williams
SHW
$84.1B
$259M 2.07%
1,343,961
-183,429
-12% -$33.1M
WAB icon
19
Wabtec
WAB
$50.3B
$249M 1.99%
4,325,361
-1,996,993
-32% -$113M
EXEL icon
20
Exelixis
EXEL
$13.4B
$243M 1.95%
10,250,000
+250,000
+3% +$5.79M
BMY icon
21
Bristol-Myers Squibb
BMY
$137B
$213M 1.71%
+3,625,000
New +$217M
XLRN
22
DELISTED
Acceleron Pharma
XLRN
$200M 1.6%
2,100,000
-75,000
-3% -$7.23M
BABA icon
23
Alibaba
BABA
$286B
$200M 1.6%
926,700
-196,800
-18% -$41M
PANW icon
24
Palo Alto Networks
PANW
$292B
$196M 1.57%
5,112,630
-807,696
-14% -$28.5M
EQIX icon
25
Equinix
EQIX
$105B
$188M 1.5%
267,597
-14,336
-5% -$9.7M
1
2 3 4 5

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q2 2020 Portfolio in Review

As of Q2 2020, Thomas Steyer held 137 positions worth $12.5B, up 7.2% from $11.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Thomas Steyer withdrew a net $1.62B in Q2 2020, closing 18 positions and reducing 37 holdings. Its most notable exit was Allergan plc, an estimated $1.65B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 52% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Thomas Steyer opened a new position in T-Mobile US worth $360M.

  • Thomas Steyer's largest Q2 2020 buy was T-Mobile US: 3,457,631 shares worth $360M.
  • Thomas Steyer added most to Blackstone in Q2 2020, an estimated $125M increase.
  • Thomas Steyer's biggest Q2 2020 reduction was Cigna, cutting an estimated $142M.
  • Thomas Steyer fully exited Allergan plc in Q2 2020, selling an estimated $1.65B.
  • Thomas Steyer's ten largest holdings make up 33% of its $12.5B portfolio in Q2 2020.
  • Thomas Steyer opened 32 new positions and closed 18 in Q2 2020.
  • Thomas Steyer's portfolio value rose 7.2% quarter-over-quarter to $12.5B.

Based on Farallon Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.